Schwab, D., Sturm, C., Portron, A., Fuerst-Recktenwald, S., Hainzl, D., Jordan, P., … DuBiner, H. Oral administration of the 11β-hydroxysteroid-dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical study. BMJ Open Ophthalmology, 1(1), e000063. https://doi.org/10.1136/bmjophth-2016-000063 (Original work published 2017)